Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
DROSPIRENONE ETHINYLESTRADIOL
Rowex Ltd
0.03 / 3 Milligram
Film Coated Tablet
2012-03-30
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ethinylestradiol / Drospirenone Leon Farma & Placebo 0.03 mg/3 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION YELLOW TABLETS (ACTIVE TABLETS): Each film-coated tablet contains 0.03 mg of ethinylestradiol and 3 mg of drospirenone Excipients: Lactose monohydrate 62 mg WHITE TABLETS (PLACEBO TABLETS) The tablet does not contain active substances Excipient: Lactose, anhydrous 89.5 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Active tablets: Yellow, round film-coated tablets. Placebo tablets: White, round film-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: oral use. HOW TO TAKE ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA & PLACEBO 0.03 MG/3 MG FILM-COATED TABLETS The tablets must be taken every day at about the same time, if necessary with a little liquid in the order shown on blister pack. Tablet taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet the previous pack. Withdrawal bleeding usually starts on day 2-3 after starting the placebo tablets (last row) and may not have finished before the next pack is started. HOW TO START ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA & PLACEBO 0.03 MG/3 MG FILM-COATED TABLETS • No preceding hormonal contraceptive use (in the past month) Tablet-taking has to start on day 1 of the woman’s natural cycle (i.e. the first day of her menstrual bleeding). • Changing from another combined oral contraceptive (COC) The woman should start Ethinylestradiol / Drospirenone Leon Farma & Placebo 0.03 mg/3 mg Film-coated Tablets on the Read the complete document